9.871USD+9.871After-hours 07/27, 20:00 (ET)
524.83MMarket Cap
LossP/E TTM
CADL Balance Sheet
You can check out the annual or quarterly balance sheets of Candel Therapeutics Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
FAQs
Which balance sheet metrics matter most when analyzing CADL stock?
Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.
What is the difference between assets, liabilities, and shareholders' equity?
Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.
What is the difference between current and non-current items?
Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.
How Much Cash Does Candel Therapeutics Inc Have?
In its most recent quarterly, Candel Therapeutics Inc had 194.83M in cash and cash equivalents.
What Are Candel Therapeutics Inc's Total Assets?
As of the latest reported quarter, Candel Therapeutics Inc's total assets were 125.19M, consisting of 121.39M in current assets and 3.81M in non-current assets.
How Much Shareholders' Equity Does Candel Therapeutics Inc Have?
Candel Therapeutics Inc reported 51.92M in total shareholders' equity as of the latest reported quarter.